Does MEPOLIZUMAB Cause Pulmonary mass? 450 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 450 reports of Pulmonary mass have been filed in association with MEPOLIZUMAB (Nucala). This represents 1.1% of all adverse event reports for MEPOLIZUMAB.
450
Reports of Pulmonary mass with MEPOLIZUMAB
1.1%
of all MEPOLIZUMAB reports
2
Deaths
244
Hospitalizations
How Dangerous Is Pulmonary mass From MEPOLIZUMAB?
Of the 450 reports, 2 (0.4%) resulted in death, 244 (54.2%) required hospitalization, and 4 (0.9%) were considered life-threatening.
Is Pulmonary mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 450 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Pulmonary mass?
ADALIMUMAB (1,299)
METHOTREXATE (1,153)
PREDNISONE (755)
ALBUTEROL (736)
ETANERCEPT (665)
TIOTROPIUM (624)
RITUXIMAB (531)
BUDESONIDE\FORMOTEROL (464)
LEFLUNOMIDE (430)
TOCILIZUMAB (401)
Which MEPOLIZUMAB Alternatives Have Lower Pulmonary mass Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE